Vyacheslav Kosorukov

Dr. Kosorukov is a biotechnology scientist and R&D executive with over 25 years of leadership in molecular biology, oncology, immunotherapy, and peptide drug development. Since 2016, he has served as Chief Scientific Officer of PVP Labs, directing the company’s scientific strategy, discovery programs, and translational research.

Under his guidance, PVP Labs has advanced several proprietary compounds, including Taphalgin® and Arvidal®. He supervises the search and development of new peptide candidates, organization of preclinical screening and translational studies, and scientific evaluation for patent protection.

He has extensive experience overseeing discovery, preclinical, and clinical development programs (Phases I–III), including scientific design, experimental validation, and coordination of multidisciplinary research teams across biotechnology and oncology fields.